Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 182Ovarian Neoplasms 92Carcinoma, Ovarian Epithelial 46Fallopian Tube Neoplasms 35Endometrial Neoplasms 29Peritoneal Neoplasms 23Stomach Neoplasms 18Colorectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Neoplasms 11Vulvar Neoplasms 9Recurrence 9Lung Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Pancreatic Neoplasms 7Locally Advanced Cervical Cancer 7Brenner Tumor 7Uterine Neoplasms 6Testicular Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Neoplasm Metastasis 6Carcinoma 6Urinary Bladder Neoplasms 5Sarcoma 5Colonic Neoplasms 5Breast Neoplasms 5Vaginal Neoplasms 4Triple Negative Breast Neoplasms 4Teratoma 4Small Cell Lung Carcinoma 4

Interventions

Paclitaxel 2etoposide phosphate 1Taxes 1Platinum 1Nivolumab 1Immunoglobulin G 1Disulfides 1Cisplatin 1Carboplatin 1Bleomycin 1Bevacizumab 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sertoli-Leydig Cell Tumor × Cisplatin × Gynecologic × Clear all
NCT01042522 2022-01-25

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

GOG Foundation

Phase 2 Unknown
63 enrolled 16 charts
Gynecologic

Granulosa cell tumor of the ovary, Ovarian gynandroblastoma, Sertoli-Leydig Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡